{"transactions":[{"id":1660985,"issuer":{"id":88003,"kind":"organization","name":"UpHealth, Inc.","symbol":"UPHL"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-02T18:22:18.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continued service to the Company, the Restricted Stock Units (\"RSUs\") shall vest on January 1, 2025; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company."}],"balance_after":160606,"source":{"system":"sec-edgar","filing":"0001062993-24-001879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000106299324001879/form4.xml","form_type":"4"}},{"id":1958463,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T09:28:18.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":21096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":22.71,"expiration_date":"2031-11-04","underlying":"Common Shares","underlying_shares":21096},"source":{"system":"sec-edgar","filing":"0001209191-23-017717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919123017717/doc4.xml","form_type":"4"}},{"id":1958462,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T09:28:18.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":21603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":21.47,"expiration_date":"2030-09-14","underlying":"Common Shares","underlying_shares":21603},"source":{"system":"sec-edgar","filing":"0001209191-23-017717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919123017717/doc4.xml","form_type":"4"}},{"id":1958461,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T09:28:18.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":58608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.65,"expiration_date":"2029-08-22","underlying":"Common Shares","underlying_shares":58608},"source":{"system":"sec-edgar","filing":"0001209191-23-017717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919123017717/doc4.xml","form_type":"4"}},{"id":1958460,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-10T09:28:18.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each then-outstanding and unexercised Issuer stock option (whether vested or unvested) was canceled and converted into the right to receive an amount (subject to any withholding tax) in cash, without interest, equal to the product of (a) the excess, if any, of (i) the Per Share Consideration over (ii) the applicable exercise price for such option, multiplied by (b) the total number of Issuer common shares subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":19.71,"expiration_date":"2028-07-22","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-23-017717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919123017717/doc4.xml","form_type":"4"}},{"id":1958459,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-10T09:28:18.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":3673,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2023, Sumitovant Biopharma Ltd. (\"Sumitovant\") acquired all of the common shares of the Issuer not previously held by it pursuant to the terms of an Agreement and Plan of Merger, dated as of October 23, 2022 (the \"Merger Agreement\"), and a related Statutory Merger Agreement (the \"Statutory Merger Agreement\", and together with the Merger Agreement, the \"Merger Agreements\"), entered into by and among the Issuer, Sumitovant, Zeus Sciences Ltd., a wholly owned subsidiary of Sumitovant (\"Merger Sub\"), and other parties thereto.  Pursuant to the Merger Agreements, Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Sumitovant (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the vested portion of 9,859 restricted stock units (\"RSUs\") granted to the Reporting Person as the annual non-employee director grant, which pro-ration was calculated based on the number of days the Reporting Person had served as a director from October 26, 2022 to the effective time of the Merger (the \"Effective Time\") (by using 365 days for a full year), which was equal to 3,673 (rounded down to the nearest whole RSU). Such vested RSUs were converted into the RSU Consideration (as defined below). The remaining 6,186 unvested RSUs were forfeited without consideration as of the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU outstanding immediately prior to the Effective Time that had not been settled in Issuer common shares was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash, without interest, equal to the product of (a) $27.00 in cash, without interest and less any applicable withholding taxes (the \"Per Share Consideration\"), multiplied by (b) the total number of Issuer common shares subject to such RSU immediately prior to the Effective Time (the \"RSU Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-017717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919123017717/doc4.xml","form_type":"4"}},{"id":2081242,"issuer":{"id":88003,"kind":"organization","name":"UpHealth, Inc.","symbol":"UPHL"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-19T20:31:40.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":60606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Subject to the Reporting Person's continued service to UpHealth, Inc. (the \"Company\"), 1/3 of the Restricted Stock Unit (\"RSUs\") shall vest on November 22, 2023, and the remaining 2/3 of the RSUs shall vest quarterly on each March 7, May 22, and August 22, of each year such that the RSUs shall be fully vested on November 22, 2025. In the event that Reporting Person's services to the Company ceases prior to any one or more of the vesting dates specified above due to (i) Reporting Person's resignation, (ii) if Reporting Person chooses not to stand for reelection as a member of the Board (if applicable), or"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"(iii) Reporting Person's termination for cause, then such member of the Board will permanently forfeit all RSUs that are unvested as of such date that the services to the Company ceases. However, if Reporting Person's services to the Company ceases due to (i) Reporting Person's termination by the Board other than for cause, (ii) the decision of the Board not to re-nominate Reporting Person for election to the Board (if applicable) other than for cause, (iii) Reporting Person's Disability (as defined in the Plan), or (iv) Reporting Person's death, all RSUs shall immediately vest. In addition, in the event of a Change of Control of the Company (as defined in the Plan), all RSUs shall immediately vest."}],"balance_after":60606,"source":{"system":"sec-edgar","filing":"0001062993-22-024180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000106299322024180/form4.xml","form_type":"4"}},{"id":2130249,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-28T16:41:58.000Z","date":"2022-10-26","kind":"grant","acquired":true,"shares":9859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units (\"RSUs\") granted to the Reporting Person as the annual non-employee director grant.  The RSUs shall (x) vest in full on the earlier to occur of (i) October 26, 2023 and (ii) the date that is one day prior to the Issuer's 2023 annual shareholder meeting, subject in each case to the Reporting Person providing continuous service to the Issuer on such date, or (y) to the extent the RSUs have not vested as of the Effective Time, vest pro rata based on the number of days the Reporting Person has served since October 26, 2022 (by using 365 days for a full year), and the vested RSUs shall be entitled to the RSU Consideration as set forth in Section 2.04(b)(i) of the Merger Agreement, and the unvested RSUs shall be forfeited without consideration as of the Effective Time."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each capitalized term not defined above has the meaning assigned to it in that certain Agreement and Plan of Merger by and among the Issuer, Sumitovant Biopharma Ltd., Zeus Sciences Ltd., and, solely with respect to Article IX and Annex A, Sumitomo Pharma Co., Ltd. dated October 23, 2022 (the \"Merger Agreement\")."}],"balance_after":9859,"source":{"system":"sec-edgar","filing":"0001209191-22-054816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919122054816/doc4.xml","form_type":"4"}},{"id":2342595,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2022-03-09T21:48:30.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":10475,"price":130.09,"value":1362692.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award."}],"balance_after":98981,"source":{"system":"sec-edgar","filing":"0001022079-22-000058","document":"wf-form4_164686249689113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000058/wf-form4_164686249689113.xml","form_type":"4"}},{"id":2342594,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2022-03-09T21:48:30.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":20780,"price":130.09,"value":2703270.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d)."}],"balance_after":109456,"source":{"system":"sec-edgar","filing":"0001022079-22-000058","document":"wf-form4_164686249689113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000058/wf-form4_164686249689113.xml","form_type":"4"}},{"id":2369839,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2022-03-01T00:37:55.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":10932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on the first annual anniversary of the grant date."}],"balance_after":10932,"derivative":{"exercise_price":127.725,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":10932},"source":{"system":"sec-edgar","filing":"0001022079-22-000033","document":"wf-form4_164609505201179.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000033/wf-form4_164609505201179.xml","form_type":"4"}},{"id":2369838,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2022-03-01T00:37:55.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":2251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted share units."}],"balance_after":88676,"source":{"system":"sec-edgar","filing":"0001022079-22-000033","document":"wf-form4_164609505201179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000033/wf-form4_164609505201179.xml","form_type":"4"}},{"id":2372946,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2022-02-26T00:08:02.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":694,"price":130.23,"value":90379.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units."}],"balance_after":86425,"source":{"system":"sec-edgar","filing":"0001022079-22-000017","document":"wf-form4_164583402858760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000017/wf-form4_164583402858760.xml","form_type":"4"}},{"id":2372945,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2022-02-26T00:08:02.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":1673,"price":130.09,"value":217640.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units."}],"balance_after":87119,"source":{"system":"sec-edgar","filing":"0001022079-22-000017","document":"wf-form4_164583402858760.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000017/wf-form4_164583402858760.xml","form_type":"4"}},{"id":2519204,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-09T17:38:18.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":21096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option vest and become exercisable on the earlier of (a) November 5, 2022, and (b) the date that is one day prior to the Issuer's 2022 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date."}],"balance_after":21096,"derivative":{"exercise_price":22.71,"expiration_date":"2031-11-04","underlying":"Common Shares","underlying_shares":21096},"source":{"system":"sec-edgar","filing":"0001209191-21-063677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919121063677/doc4.xml","form_type":"4"}},{"id":2795348,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-03-11T21:27:31.000Z","date":"2021-03-09","kind":"tax_withholding","acquired":false,"shares":6403,"price":115.42,"value":739034.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":88792,"source":{"system":"sec-edgar","filing":"0001022079-21-000054","document":"wf-form4_161549803034551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207921000054/wf-form4_161549803034551.xml","form_type":"4"}},{"id":2795347,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-03-11T21:27:31.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":17322,"price":115.42,"value":1999305.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d)."}],"balance_after":95195,"source":{"system":"sec-edgar","filing":"0001022079-21-000054","document":"wf-form4_161549803034551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207921000054/wf-form4_161549803034551.xml","form_type":"4"}},{"id":2833555,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-02-25T21:32:58.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":541,"price":121.19,"value":65563.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units."}],"balance_after":77873,"source":{"system":"sec-edgar","filing":"0001022079-21-000040","document":"wf-form4_161428874135843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207921000040/wf-form4_161428874135843.xml","form_type":"4"}},{"id":2833554,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-02-25T21:32:58.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":830,"price":121.15,"value":100554.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units."}],"balance_after":78414,"source":{"system":"sec-edgar","filing":"0001022079-21-000040","document":"wf-form4_161428874135843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207921000040/wf-form4_161428874135843.xml","form_type":"4"}},{"id":2847030,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2021-02-20T01:36:55.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":31774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on the first annual anniversary of the grant date."}],"balance_after":31774,"derivative":{"exercise_price":121.805,"expiration_date":"2031-02-17","underlying":"Common Stock","underlying_shares":31774},"source":{"system":"sec-edgar","filing":"0001022079-21-000019","document":"wf-form4_161378500022070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207921000019/wf-form4_161378500022070.xml","form_type":"4"}},{"id":2847029,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-02-20T01:36:55.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":5665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted share units."}],"balance_after":79244,"source":{"system":"sec-edgar","filing":"0001022079-21-000019","document":"wf-form4_161378500022070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207921000019/wf-form4_161378500022070.xml","form_type":"4"}},{"id":2931828,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2020-12-28T21:27:20.000Z","date":"2020-12-24","kind":"exercise","acquired":false,"shares":81756,"price":66.51,"value":5437591.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019."}],"balance_after":0,"derivative":{"exercise_price":66.51,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":81756},"source":{"system":"sec-edgar","filing":"0001022079-20-000200","document":"wf-form4_160919082499081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000200/wf-form4_160919082499081.xml","form_type":"4"}},{"id":2931827,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-12-28T21:27:20.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":22563,"price":121.178,"value":2734139.214,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $120.64 to $121.58.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73579,"source":{"system":"sec-edgar","filing":"0001022079-20-000200","document":"wf-form4_160919082499081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000200/wf-form4_160919082499081.xml","form_type":"4"}},{"id":2931826,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-12-28T21:27:20.000Z","date":"2020-12-24","kind":"sale","acquired":false,"shares":59193,"price":120.057,"value":7106534.001,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $119.64 to $120.63.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":96142,"source":{"system":"sec-edgar","filing":"0001022079-20-000200","document":"wf-form4_160919082499081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000200/wf-form4_160919082499081.xml","form_type":"4"}},{"id":2931825,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-12-28T21:27:20.000Z","date":"2020-12-24","kind":"exercise","acquired":true,"shares":81756,"price":66.51,"value":5437591.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 23, 2020."}],"balance_after":155335,"source":{"system":"sec-edgar","filing":"0001022079-20-000200","document":"wf-form4_160919082499081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000200/wf-form4_160919082499081.xml","form_type":"4"}},{"id":3027882,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T16:15:14.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":21603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option vest and become exercisable on the earlier of (a) September 15, 2021, and (b) the date that is one day prior to the Issuer's 2021 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date."}],"balance_after":21603,"derivative":{"exercise_price":21.47,"expiration_date":"2030-09-14","underlying":"Common Shares","underlying_shares":21603},"source":{"system":"sec-edgar","filing":"0001209191-20-050879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919120050879/doc4.xml","form_type":"4"}},{"id":3115164,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2020-06-10T20:33:00.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":72596,"price":71.17,"value":5166657.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018."}],"balance_after":0,"derivative":{"exercise_price":71.17,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":72596},"source":{"system":"sec-edgar","filing":"0001022079-20-000136","document":"wf-form4_159182116205657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000136/wf-form4_159182116205657.xml","form_type":"4"}},{"id":3115163,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:00.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":8524,"price":118.604,"value":1010980.496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $118.16 to $119.10.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73579,"source":{"system":"sec-edgar","filing":"0001022079-20-000136","document":"wf-form4_159182116205657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000136/wf-form4_159182116205657.xml","form_type":"4"}},{"id":3115162,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:00.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":18246,"price":117.649,"value":2146623.654,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $117.15 to $118.14.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":82103,"source":{"system":"sec-edgar","filing":"0001022079-20-000136","document":"wf-form4_159182116205657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000136/wf-form4_159182116205657.xml","form_type":"4"}},{"id":3115161,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:00.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":45826,"price":116.811,"value":5352980.886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $116.15 to $117.14.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100349,"source":{"system":"sec-edgar","filing":"0001022079-20-000136","document":"wf-form4_159182116205657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000136/wf-form4_159182116205657.xml","form_type":"4"}},{"id":3115160,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:00.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":72596,"price":71.17,"value":5166657.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020."}],"balance_after":146175,"source":{"system":"sec-edgar","filing":"0001022079-20-000136","document":"wf-form4_159182116205657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000136/wf-form4_159182116205657.xml","form_type":"4"}},{"id":3214099,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-03-12T20:58:50.000Z","date":"2020-03-10","kind":"tax_withholding","acquired":false,"shares":3870,"price":106.46,"value":412000.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award."}],"balance_after":73579,"source":{"system":"sec-edgar","filing":"0001022079-20-000075","document":"wf-form4_158404671319326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000075/wf-form4_158404671319326.xml","form_type":"4"}},{"id":3214098,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-03-12T20:58:50.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":7693,"price":106.46,"value":818996.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d)."}],"balance_after":77449,"source":{"system":"sec-edgar","filing":"0001022079-20-000075","document":"wf-form4_158404671319326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000075/wf-form4_158404671319326.xml","form_type":"4"}},{"id":3244499,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-02-28T00:22:22.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":1195,"price":112.9,"value":134915.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":69756,"source":{"system":"sec-edgar","filing":"0001022079-20-000057","document":"wf-form4_158284932517296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000057/wf-form4_158284932517296.xml","form_type":"4"}},{"id":3246952,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-02-26T21:29:46.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":565,"price":113.34,"value":64037.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units."}],"balance_after":70951,"source":{"system":"sec-edgar","filing":"0001022079-20-000042","document":"wf-form4_158275256892243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000042/wf-form4_158275256892243.xml","form_type":"4"}},{"id":3246951,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-02-26T21:29:46.000Z","date":"2020-02-24","kind":"tax_withholding","acquired":false,"shares":653,"price":112.17,"value":73247.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units."}],"balance_after":71516,"source":{"system":"sec-edgar","filing":"0001022079-20-000042","document":"wf-form4_158275256892243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000042/wf-form4_158275256892243.xml","form_type":"4"}},{"id":3260358,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2020-02-21T01:33:05.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":40120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on the first annual anniversary of the grant date."}],"balance_after":40120,"derivative":{"exercise_price":112.17,"expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":40120},"source":{"system":"sec-edgar","filing":"0001022079-20-000028","document":"wf-form4_158224876751569.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000028/wf-form4_158224876751569.xml","form_type":"4"}},{"id":3260357,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-02-21T01:33:05.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":6152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted share units."}],"balance_after":72169,"source":{"system":"sec-edgar","filing":"0001022079-20-000028","document":"wf-form4_158224876751569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207920000028/wf-form4_158224876751569.xml","form_type":"4"}},{"id":3427902,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-27T16:44:05.000Z","date":"2019-08-23","kind":"grant","acquired":true,"shares":58608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option vest and become exercisable on the earlier of (a) August 23, 2020, and (b) the date that is one day prior to the Issuer's 2020 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date."}],"balance_after":58608,"derivative":{"exercise_price":7.65,"expiration_date":"2029-08-22","underlying":"Common Shares","underlying_shares":58608},"source":{"system":"sec-edgar","filing":"0001209191-19-047529","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919119047529/doc4.xml","form_type":"4"}},{"id":3488378,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-06-17T20:35:13.000Z","date":"2019-06-13","kind":"exercise","acquired":false,"shares":73005,"price":52.165,"value":3808305.825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017."}],"balance_after":0,"derivative":{"exercise_price":52.165,"expiration_date":"2024-02-13","underlying":"Common Stock","underlying_shares":73005},"source":{"system":"sec-edgar","filing":"0001022079-19-000147","document":"wf-form4_156080369748155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000147/wf-form4_156080369748155.xml","form_type":"4"}},{"id":3488377,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-06-17T20:35:13.000Z","date":"2019-06-13","kind":"sale","acquired":false,"shares":73005,"price":100,"value":7300500.0,"ownership":{"direct":true},"balance_after":66017,"source":{"system":"sec-edgar","filing":"0001022079-19-000147","document":"wf-form4_156080369748155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000147/wf-form4_156080369748155.xml","form_type":"4"}},{"id":3488376,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-06-17T20:35:13.000Z","date":"2019-06-13","kind":"exercise","acquired":true,"shares":73005,"price":52.165,"value":3808305.825,"ownership":{"direct":true},"balance_after":139022,"source":{"system":"sec-edgar","filing":"0001022079-19-000147","document":"wf-form4_156080369748155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000147/wf-form4_156080369748155.xml","form_type":"4"}},{"id":3614909,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-03-05T21:30:31.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":5288,"price":86.86,"value":459315.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":66017,"source":{"system":"sec-edgar","filing":"0001022079-19-000091","document":"wf-form4_155182141718438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000091/wf-form4_155182141718438.xml","form_type":"4"}},{"id":3614908,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-03-05T21:30:31.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":10736,"price":86.86,"value":932528.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d)."}],"balance_after":71305,"source":{"system":"sec-edgar","filing":"0001022079-19-000091","document":"wf-form4_155182141718438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000091/wf-form4_155182141718438.xml","form_type":"4"}},{"id":3627224,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-02-28T22:21:11.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":1556,"price":87.84,"value":136679.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":60569,"source":{"system":"sec-edgar","filing":"0001022079-19-000074","document":"wf-form4_155139245730159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000074/wf-form4_155139245730159.xml","form_type":"4"}},{"id":3629764,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-02-27T23:29:52.000Z","date":"2019-02-25","kind":"tax_withholding","acquired":false,"shares":660,"price":88.24,"value":58238.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":62125,"source":{"system":"sec-edgar","filing":"0001022079-19-000060","document":"wf-form4_155131017859571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000060/wf-form4_155131017859571.xml","form_type":"4"}},{"id":3636677,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-02-26T00:58:07.000Z","date":"2019-02-22","kind":"tax_withholding","acquired":false,"shares":610,"price":88.39,"value":53917.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":62785,"source":{"system":"sec-edgar","filing":"0001022079-19-000042","document":"wf-form4_155114267401719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000042/wf-form4_155114267401719.xml","form_type":"4"}},{"id":3647297,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2019-02-20T23:26:42.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":63259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on the first annual anniversary of the grant date."}],"balance_after":63259,"derivative":{"exercise_price":86.63,"expiration_date":"2029-02-18","underlying":"Common Stock","underlying_shares":63259},"source":{"system":"sec-edgar","filing":"0001022079-19-000022","document":"wf-form4_155070518922803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000022/wf-form4_155070518922803.xml","form_type":"4"}},{"id":3647296,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-02-20T23:26:42.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":5195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted share units."}],"balance_after":63395,"source":{"system":"sec-edgar","filing":"0001022079-19-000022","document":"wf-form4_155070518922803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207919000022/wf-form4_155070518922803.xml","form_type":"4"}},{"id":3862115,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-24T19:10:07.000Z","date":"2018-07-23","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option vest and become exercisable on July 23, 2019, with the balance of the shares vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":45000,"derivative":{"exercise_price":19.71,"expiration_date":"2028-07-22","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-043812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505998/000120919118043812/doc4.xml","form_type":"4"}},{"id":3916060,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-05-29T20:37:26.000Z","date":"2018-05-25","kind":"exercise","acquired":false,"shares":61533,"price":58.365,"value":3591373.545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested in three equal annual installments beginning with the first on August 19, 2014, the second on August 19, 2015 and the final on August 19, 2016."}],"balance_after":0,"derivative":{"exercise_price":58.365,"expiration_date":"2023-08-19","underlying":"Common Stock","underlying_shares":61533},"source":{"system":"sec-edgar","filing":"0001022079-18-000133","document":"wf-form4_152762623294219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000133/wf-form4_152762623294219.xml","form_type":"4"}},{"id":3916059,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-05-29T20:37:26.000Z","date":"2018-05-25","kind":"sale","acquired":false,"shares":24960,"price":106.139,"value":2649229.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $106.00 to $106.62.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":58200,"source":{"system":"sec-edgar","filing":"0001022079-18-000133","document":"wf-form4_152762623294219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000133/wf-form4_152762623294219.xml","form_type":"4"}},{"id":3916058,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-05-29T20:37:26.000Z","date":"2018-05-25","kind":"sale","acquired":false,"shares":36573,"price":105.418,"value":3855452.514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $105.00 to $105.98.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":83160,"source":{"system":"sec-edgar","filing":"0001022079-18-000133","document":"wf-form4_152762623294219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000133/wf-form4_152762623294219.xml","form_type":"4"}},{"id":3916057,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-05-29T20:37:26.000Z","date":"2018-05-25","kind":"exercise","acquired":true,"shares":61533,"price":58.365,"value":3591373.545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018."}],"balance_after":119733,"source":{"system":"sec-edgar","filing":"0001022079-18-000133","document":"wf-form4_152762623294219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000133/wf-form4_152762623294219.xml","form_type":"4"}},{"id":4012123,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-07T00:52:01.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":6471,"price":101,"value":653571.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award."}],"balance_after":58200,"source":{"system":"sec-edgar","filing":"0001022079-18-000094","document":"wf-form4_152038390649131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000094/wf-form4_152038390649131.xml","form_type":"4"}},{"id":4012122,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-07T00:52:01.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":13137,"price":101,"value":1326837.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d)."}],"balance_after":64671,"source":{"system":"sec-edgar","filing":"0001022079-18-000094","document":"wf-form4_152038390649131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000094/wf-form4_152038390649131.xml","form_type":"4"}},{"id":4012121,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-07T00:47:41.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":779,"price":101.43,"value":79013.97,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Amendment to the original Form 4 filed on March 1, 2018 is made solely to correct an administrative error with respect to the amount of shares reported to the issuer as having been disposed of, as reported on line 4 in Table 1 of the Form 4 as originally filed."},{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":51534,"source":{"system":"sec-edgar","filing":"0001022079-18-000093","document":"wf-form4a_152038364031486.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000093/wf-form4a_152038364031486.xml","form_type":"4/A","original_submission_date":"2018-03-01"}},{"id":4012120,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-07T00:45:24.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":1454,"price":101.43,"value":147479.22,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This Amendment to the original Form 4 filed on February 27, 2018 is made solely to correct an administrative error with respect to the amount of shares reported to the issuer as having been disposed of, as reported on line 4 in Table 1 of the Form 4 as originally filed."},{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":52313,"source":{"system":"sec-edgar","filing":"0001022079-18-000092","document":"wf-form4a_152038350470927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000092/wf-form4a_152038350470927.xml","form_type":"4/A","original_submission_date":"2018-02-27"}},{"id":4012119,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-07T00:45:24.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":592,"price":102.69,"value":60792.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":53767,"source":{"system":"sec-edgar","filing":"0001022079-18-000092","document":"wf-form4a_152038350470927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000092/wf-form4a_152038350470927.xml","form_type":"4/A","original_submission_date":"2018-02-27"}},{"id":4024950,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-01T22:03:08.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":585,"price":101.43,"value":59336.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":52090,"source":{"system":"sec-edgar","filing":"0001022079-18-000066","document":"wf-form4_151994174862559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000066/wf-form4_151994174862559.xml","form_type":"4"}},{"id":4031339,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-02-27T21:39:22.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":1092,"price":101.43,"value":110761.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":52675,"source":{"system":"sec-edgar","filing":"0001022079-18-000053","document":"wf-form4_151976754246593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000053/wf-form4_151976754246593.xml","form_type":"4"}},{"id":4031338,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-02-27T21:39:22.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":592,"price":102.69,"value":60792.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":53767,"source":{"system":"sec-edgar","filing":"0001022079-18-000053","document":"wf-form4_151976754246593.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000053/wf-form4_151976754246593.xml","form_type":"4"}},{"id":4045311,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2018-02-22T00:39:01.000Z","date":"2018-02-19","kind":"grant","acquired":true,"shares":50764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on the first annual anniversary of the grant date."}],"balance_after":50764,"derivative":{"exercise_price":103.57,"expiration_date":"2028-02-19","underlying":"Common Stock","underlying_shares":50764},"source":{"system":"sec-edgar","filing":"0001022079-18-000032","document":"wf-form4_151925992641098.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000032/wf-form4_151925992641098.xml","form_type":"4"}},{"id":4045310,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-02-22T00:39:01.000Z","date":"2018-02-19","kind":"grant","acquired":true,"shares":4442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted share units."}],"balance_after":54359,"source":{"system":"sec-edgar","filing":"0001022079-18-000032","document":"wf-form4_151925992641098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207918000032/wf-form4_151925992641098.xml","form_type":"4"}},{"id":4405763,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-03-03T22:10:40.000Z","date":"2017-03-02","kind":"tax_withholding","acquired":false,"shares":7420,"price":98.12,"value":728050.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award."}],"balance_after":49917,"source":{"system":"sec-edgar","filing":"0001022079-17-000097","document":"wf-form4_148857902274030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000097/wf-form4_148857902274030.xml","form_type":"4"}},{"id":4405762,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-03-03T22:10:40.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":14309,"price":98.12,"value":1403999.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d)."}],"balance_after":57337,"source":{"system":"sec-edgar","filing":"0001022079-17-000097","document":"wf-form4_148857902274030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000097/wf-form4_148857902274030.xml","form_type":"4"}},{"id":4410838,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-03-02T21:47:00.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":625,"price":96.42,"value":60262.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":43028,"source":{"system":"sec-edgar","filing":"0001022079-17-000084","document":"wf-form4_148849120636793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000084/wf-form4_148849120636793.xml","form_type":"4"}},{"id":4418706,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-02-28T21:45:25.000Z","date":"2017-02-24","kind":"tax_withholding","acquired":false,"shares":585,"price":95.68,"value":55972.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares."}],"balance_after":43653,"source":{"system":"sec-edgar","filing":"0001022079-17-000067","document":"wf-form4_148831831097670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000067/wf-form4_148831831097670.xml","form_type":"4"}},{"id":4428486,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2017-02-23T23:14:51.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":57606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal annual installments beginning on the first annual anniversary of the grant date."}],"balance_after":57606,"derivative":{"exercise_price":95.795,"expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":57606},"source":{"system":"sec-edgar","filing":"0001022079-17-000048","document":"wf-form4_148789167843581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000048/wf-form4_148789167843581.xml","form_type":"4"}},{"id":4428485,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-02-23T23:14:51.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":4802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of restricted share units."}],"balance_after":44238,"source":{"system":"sec-edgar","filing":"0001022079-17-000048","document":"wf-form4_148789167843581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000048/wf-form4_148789167843581.xml","form_type":"4"}},{"id":4446404,"issuer":{"id":2118,"kind":"organization","name":"QUEST DIAGNOSTICS INC","symbol":"DGX"},"owners":[{"id":94659,"kind":"person","name":"GUINAN MARK","position":1,"cik":"0001505998","reported_name":"GUINAN MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-02-15T21:40:04.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":1451,"price":93.85,"value":136176.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units."}],"balance_after":39436,"source":{"system":"sec-edgar","filing":"0001022079-17-000022","document":"wf-form4_148719479171550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207917000022/wf-form4_148719479171550.xml","form_type":"4"}}]}